News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Sabine D. Brookman-May: ESSA terminates Phase 2 trial
Sabine D. Brookman-May/X
Nov 3, 2024, 09:32

Sabine D. Brookman-May: ESSA terminates Phase 2 trial

Sabine D. Brookman-May posted on X:

“ESSA terminates Phase 2 trial: masofaniten (Epi-7386/N-terminal AR antagonist) plus enzalutamide vs enza mono in mCRPC patients naïve to 2nd gen antiandrogens (+ other combination studies) At futility analysis higher rate of PSA90 with enza mono.”

Sabine D. Brookman-May: ESSA terminates Phase 2 trial

Sabine D. Brookman-May is the Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences. Previously, she was the Vice President of Bladder Cancer Development, Research and Development at Janssen Pharmaceutical Companies of Johnson & Johnson. She also serves as a professor of Urology at Ludwig Maximilian University of Munich, specializing in Urology, Oncology, and Sports and Exercise Medicine.

cancer enza mono Enzalutamide masofaniten OncoDaily Oncology Sabine D. Brookman-May
Special Coverage
Blog
Apr 1, 2025, 19:09
Sally Susman: Thank you for joining me for Memoir March
Blog
Apr 1, 2025, 19:03
Megan-Claire J. Chase: Amazing team from Pink Warrior Angels at the exhibitor table right next to mine
Blog
Apr 1, 2025, 19:03
AIQ Solutions Tackles the Complex Reality of Unequal Metastatic Cancer Treatment Responses - CancerX
Blog
Apr 1, 2025, 18:58
Kevin Jackson Announces New Role as Lead Events Manager at UF Health Cancer Center
Blog
Apr 1, 2025, 18:48
Understanding Abnormal Coagulation at EPHOC 2025 - MENA Conference
Blog
Apr 1, 2025, 18:43
Debra Montague Joins Medscape Faculty Steering Committee as Patient Representative
Blog
Apr 1, 2025, 18:37
Binay Shah: Three Timely Levers to help bridge growing gap in Cancer Care
Insight
Apr 1, 2025, 18:33
Fumiko Ladd Chino: Over 1,200 scientists may leave the US due to disruptions from the Trump administration
Blog
Apr 1, 2025, 18:29
How EveryGrant is Helping Grantmakers Make a Global Impact - Conquer Cancer, the ASCO Foundation
Blog
Apr 1, 2025, 18:28
How tobacco smoking contributes to development of cancers of the head and neck - IARC/WHO
Blog
Apr 1, 2025, 18:26
Benjamin Perrotta: St. Baldricks was a success
Blog
Apr 1, 2025, 18:22
Last days to submit your abstract and topic proposal for SIOP 2025